Cerulea Clinical Trials delivers ophthalmic clinical trials for Australian and international biopharmaceutical and medtech companies – and is the home of investigator-initiated studies for the Centre for Eye Research Australia (CERA).

We are a fully owned, not-for-profit subsidiary of CERA and share its vision of a world free from vision loss and blindness.

Why work with us

Cerulea Clinical Trials is Australia’s largest ophthalmic clinical trials centre with over 25 years’ experience and over 200 clinical trials delivered for Australian and international biopharmaceutical and medtech companies.

Cerulea’s capabilities span Phase I-IV studies with expertise in Cell and Gene Therapy, where we bring specialised knowledge and experience to complex and innovative programs. We have a proven track record in rapid study start-up, strong recruitment, and high participant retention. Our decentralized clinical models, leading KOLs and broad patient referral network ensure the delivery of quality at speed for sponsors.

Partner with us to access Australia’s generous R&D tax incentives, mature clinical trial ecosystem, and rapid path to clinic with a globally recognized regulatory body.